On October 10, 2023, Calidi Biotherapeutics, Inc. announced the resignation of Dr. Heehyoung Lee, including all her positions on the committees of the Board, effective immediately. Dr. Lee?s resignation is for personal reasons and not due to any disagreement with the Company?s management team or the Company?s Board on any matter relating to the operations, policies or practices of the Company or any issues regarding the Company?s accounting policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1516 USD | 0.00% |
|
-21.82% | -89.96% |
Jul. 05 | Calidi Biotherapeutics to Implement 1-For-10 Reverse Stock Split | MT |
Jul. 02 | Calidi Biotherapeutics, Inc. announced that it has received $0.6 million in funding | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
- Stock Market
- Equities
- CLDI Stock
- News CALI BIOTPAR
- Calidi Biotherapeutics, Inc. Announces the Resignation of Dr. Heehyoung Lee, Including All Her Positions on the Committees of the Board